Vetoquinol SA (EPA:VETO)
France · Delayed Price · Currency is EUR 72.40
-0.60 (-0.82%)
Aug 3, 2026, 12:24 PM CET
Vetoquinol Revenue
In the year 2025, Vetoquinol had annual revenue of 525.69M EUR, down -2.51%. Vetoquinol had revenue of 268.05M in the half year ending December 31, 2025, a decrease of -1.82%.
Revenue
525.69M
Revenue Growth
-2.51%
P/S Ratio
1.61
Revenue / Employee
214.22K
Employees
2,486
Market Cap
848.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 525.69M | -13.51M | -2.51% |
| Dec 31, 2024 | 539.20M | 9.93M | 1.88% |
| Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
| Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
| Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
| Dec 31, 2020 | 427.47M | 31.48M | 7.95% |
| Dec 31, 2019 | 395.99M | 28.05M | 7.62% |
| Dec 31, 2018 | 367.94M | 15.77M | 4.48% |
| Dec 31, 2017 | 352.17M | 1.82M | 0.52% |
| Dec 31, 2016 | 350.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ramsay Générale de Santé | 5.36B |
| Clariane SE | 5.35B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Lumibird | 228.53M |
| Genfit | 70.85M |
Vetoquinol News
- 3 months ago - Vetoquinol Earnings release: Q1 2026 - Filings
- 4 months ago - Vetoquinol Earnings release: H2 2025 - Filings
- 4 months ago - Vetoquinol Slides: H2 2025 - Filings
- 4 months ago - Vetoquinol Annual report: H2 2025 - Filings
- 6 months ago - Vetoquinol Earnings release: Q4 2025 - Filings
- 9 months ago - Vetoquinol Earnings release: Q3 2025 - Filings
- 11 months ago - Vetoquinol Quarterly report: H1 2025 - Filings
- 11 months ago - Vetoquinol Slides: H1 2025 - Filings